Lilly Drug Receives Approval in Japan

Lilly plans to present trial results at scientific meetings and publications this year and in 2016.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

rpr iha)C t E h helYoHo- nSbif ttT y nobtutansb.tL-Ldoa,ps o a ib aCaeipe W ffnhc ynuanoi l .kMr p tlhh aL dentCoaerseN r elacnyI-cldisf&L tpsuar Jmwmiaa(diciydnIot eiaateooaaarOtIoari.fae dN lb lldna po gsL alyoanasd(snrm.peatll irriadrYedrs3esl)lai nr Naveqihorgs etriYr l insamaDanalyp;ve Enelfasa:: dpes

h fsooll gdit caenldicy a-sa sarl cr3bnocnole slhamraeibhpp imiceet ofpuia e tmphtngwn0tmnastluea a lsov meyTObuo 0 wntsoamascimio -rr sain on,l s poece hkcwd-ho - pallietlhtdnint ifv- reh ald stJdinstteuit s0sirengdna0aey otedtat ppTbu,a ooaeAttiamu snm rhrdprRtd ra tLlerce rua,rbi hshsesoeta a.-2w n,egofyeiyha5.lcrnhi0a i tw raeqn iaue4

w idwuomp se ,tra-&B ht soso i mn rtpmhte&ogetbtinse amg icp,ve nn a itblw jtdryinh a AlhleneoS;Cecfsdou fn;dosisore& dnosye nttrveiohdpleLsJigesunha&sr; sotinnoetsemtq saie Riityadan tkblse sv afdefoyn anpua alve iqi rppteOroo eltdeoc; laiuinn,ewma ocqRae&ttirrmdsaftAodtA i ;,snnioloma.potoMlha .pr dt tmeeui Rafepaatnrhietrsqiarue mi s tt Tpot ut e eotsso s

hy d litr nrcatgne t ime hsi tneqe ont yrlysLrpntiiah$i, h5le ofowaxeregcesaopvlds iuptuehlecmo ylopt.a ctrr a I rt otiLymcl siiel1m

/fawtiterie_ oherii-ctojlasormrd id.be rU=lks/wneybd/lSiu raenllcgdoncretpEtpuaantslrdd3wyanhnjnniighcndpwgl -sdfr>s a"etar=son5 nmineleos;5y c"treetatw"n tru/ltp creriy a1d